Baylor College of Medicine’s Cancer Genetics Laboratory will launch a sequencing-based test on the Ion Torrent PGM that uses the firm’s Ion AmpliSeq Cancer Panel to target mutations in 46 cancer genes.
Throughout 2012, the American Association for Clinical Chemistry will be exploring best laboratory practices for detecting and managing four high-prevalence disease states.
The US Food and Drug Administration recently issued draft guidance aimed to address the historic underrepresentation of women in clinical studies.
This program will answer all of your questions about body fluid analysis, particularly focusing on non-standard sources of body fluid.
Each program has been designated for 1.0 PACE continuing education credit.
Attend this webinar and learn the latest information on what’s new in laboratory testing for HBV, its subviruses, and HCV from two world-renowned experts.
The two companies have partnered to automate this assay system on the VENTANA DISCOVERY series slide staining platforms.
Bio-Rad will provide its QC products and Unity data management solutions for Siemens IMMULITE Immunoassay, Dimension Integrated Chemistry, and Dimension Vista Intelligent Lab systems.
Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90% of human breast and pancreatic cancer cases.
An independent panel convened by the NIH has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression.